VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 30 filers reported holding VASCULAR BIOGENICS LTD in Q3 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $0 | -100.0% | 10,400 | -57.0% | 0.00% | -100.0% |
| Q2 2022 | $10,000 | +66.7% | 24,200 | +12.6% | 0.00% | – |
| Q1 2022 | $6,000 | +200.0% | 21,500 | +10.3% | 0.00% | – |
| Q4 2021 | $2,000 | 0.0% | 19,500 | +91.2% | 0.00% | – |
| Q3 2021 | $2,000 | -77.8% | 10,200 | -48.7% | 0.00% | – |
| Q2 2021 | $9,000 | – | 19,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 2,593,286 | $4,382,000 | 1.02% |
| Telemetry Investments, L.L.C. | 75,000 | $127,000 | 0.20% |
| Ikarian Capital, LLC | 830,747 | $1,404,000 | 0.18% |
| DLD Asset Management, LP | 550,000 | $930,000 | 0.06% |
| Phoenix Holdings Ltd. | 1,020,000 | $1,724,000 | 0.03% |
| Spectrum Planning & Advisory Services Inc. | 16,000 | $27,000 | 0.02% |
| BOOTHBAY FUND MANAGEMENT, LLC | 79,716 | $135,000 | 0.00% |
| HBK Sorce Advisory LLC | 22,325 | $38,000 | 0.00% |
| B. Riley Wealth Management, Inc. | 12,000 | $20,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 12,155 | $21,000 | 0.00% |